Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT02594189

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

Background: Influenza A H3N2 is a flu virus. Symptoms include fever, cough, and runny nose. It can also be more serious. Researchers want to know more about ho…

United States49 participantsStarted 2015-10-31

Treatment: Live recombinantly derived A/Bethesda/MM1/H3N2 virus